BIOVERATIV THERAPEUTICS INC.;SWEDISH ORPHAN BIOVITRUM AB (PUBL)
发明人:
DUMONT, JENNIFER,JAIN, NISHA,LETHAGEN, STEFAN
申请号：
CA3044838
公开号：
CA3044838A1
申请日:
2017.12.01
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure provides methods inducing immune tolerance in a human, comprising administering to the human an effective amount of a composition or a chimeric protein comprising a clotting factor and an Fc region.
